Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 13.9B | 12.1B | 9.9B | 10.5B |
Cost of revenue | 9.8B | 8.3B | 7.3B | 7.1B |
Gross profit | 4.1B | 3.8B | 2.6B | 3.4B |
Operating expense | ||||
Research & development | 295.9M | 274.4M | 243.4M | 250.8M |
Selling general and admin | 963.4M | 942.7M | 662.0M | 612.2M |
Other operating expenses | -3.1M | 22.7M | -344K | -3.2M |
Operating income | 2.8B | 2.5B | 1.7B | 2.5B |
Non operating interest income | ||||
Income | 75.5M | 62.5M | 66.6M | 70.6M |
Expense | 47.9M | 45.9M | 44.5M | 43.4M |
Other income expense | — | — | — | — |
Pretax income | 2.5B | 2.7B | 2.0B | 2.4B |
Tax provision | 815.0M | 900.2M | 714.3M | 757.5M |
Net income | 1.7B | 1.8B | 1.3B | 1.6B |
Basic EPS | 3.5 | 3.6 | — | 3.3 |
Diluted EPS | 3.3 | 3.5 | — | 3.2 |
Basic average shares | 486.7M | 486.7M | — | 486.3M |
Diluted average shares | 510.2M | 507.0M | — | 496.9M |
EBITDA | 2.8B | 3.0B | 2.3B | 2.7B |
Net income from continuing op. | 2.5B | 2.7B | 2.0B | 2.4B |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |